Christopher P Regan Selected Research

(2-isopropyl-5-methylcyclohexyl) diphenylphosphine oxide

12/2005

In vivo antiarrhythmic and cardiac electrophysiologic effects of a novel diphenylphosphine oxide IKur blocker (2-isopropyl-5-methylcyclohexyl) diphenylphosphine oxide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christopher P Regan Research Topics

Disease

4	Migraine Disorders (Migraine) 01/2020 - 06/2009
3	Atrial Fibrillation 03/2013 - 01/2008
3	Brain Ischemia (Cerebral Ischemia) 09/2011 - 11/2007
3	Ischemia 06/2009 - 01/2009
2	Bradycardia 01/2017 - 11/2016
2	Heart Failure 12/2012 - 01/2008
2	Myocardial Infarction 11/2009 - 06/2009
2	Coronary Artery Disease (Coronary Atherosclerosis) 11/2009 - 06/2009
2	Coronary Stenosis (Coronary Artery Stenosis) 06/2009 - 02/2009
2	Myocardial Ischemia (Ischemic Heart Diseases) 06/2009 - 02/2009
2	Infarction (Infarctions) 01/2009 - 11/2007
2	Stroke (Strokes) 01/2009 - 11/2007
2	Atrial Flutter (Flutter, Atrial) 04/2007 - 12/2005
1	Pain (Aches) 01/2022
1	Wounds and Injuries (Trauma) 09/2011
1	Gliosis 09/2011
1	Hyperemia 11/2009
1	Edema (Dropsy) 01/2009
1	Neointima 05/2007
1	Atherosclerosis 05/2007
1	Vascular System Injuries 05/2007
1	Vascular Diseases (Vascular Disease) 05/2007
1	Neuralgia (Stump Neuralgia) 03/2006
1	Cardiac Arrhythmias (Arrythmia) 12/2005
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2005

Drug/Important Bio-Agent (IBA)

3	Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA 01/2020 - 02/2009
3	Serotonin (5 Hydroxytryptamine)IBA 11/2009 - 02/2009
2	Calcitonin Gene-Related PeptideIBA 01/2020 - 04/2010
2	Calcitonin Gene-Related Peptide Receptor AntagonistsIBA 01/2020 - 04/2010
2	SofosbuvirIBA 01/2017 - 11/2016
2	Amiodarone (Amiodarona)FDA LinkGeneric 01/2017 - 11/2016
2	Phosphotransferases (Kinase)IBA 09/2011 - 01/2009
2	Tryptamines (Triptans)IBA 11/2009 - 06/2009
2	Sumatriptan (Imigran)FDA LinkGeneric 11/2009 - 06/2009
2	Dizocilpine Maleate (Dizocilpine)IBA 01/2009 - 11/2007
2	BenzopyransIBA 01/2008 - 12/2005
2	Propafenone (Rythmol)FDA LinkGeneric 01/2008 - 12/2005
2	PotassiumIBA 01/2008 - 12/2005
2	methanesulfonamideIBA 01/2008 - 12/2005
2	ibutilide (Corvert)FDA LinkGeneric 04/2007 - 12/2005
1	Peptides (Polypeptides)IBA 01/2022
1	ubrogepantIBA 01/2020
1	Monoclonal AntibodiesIBA 01/2020
1	ProdrugsIBA 01/2017
1	Antiviral Agents (Antivirals)IBA 11/2016
1	uprifosbuvirIBA 11/2016
1	Anti-Arrhythmia AgentsIBA 11/2016
1	vernakalantIBA 03/2013
1	N- (6- (1- (4- fluorophenyl)- 2,2- di(pyridin- 3- yl)ethyl)pyridin- 2- yl)methanesulfonamideIBA 12/2012
1	EphA4 ReceptorIBA 09/2011
1	LigandsIBA 09/2011
1	EphrinsIBA 09/2011
1	Chondroitin Sulfate ProteoglycansIBA 09/2011
1	acetamideIBA 04/2010
1	indeneIBA 04/2010
1	Diltiazem (Cardizem)FDA LinkGeneric 02/2009
1	CalciumIBA 02/2009
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2009
1	Pharmaceutical PreparationsIBA 01/2008
1	triphenyltetrazoliumIBA 11/2007
1	Neuroprotective AgentsIBA 11/2007
1	CholesterolIBA 05/2007
1	ConnexinsIBA 05/2007
1	Connexin 43 (Connexin43)IBA 05/2007
1	Sodium Channels (Sodium Channel)IBA 03/2006
1	Sodium Channel BlockersIBA 03/2006
1	(2-isopropyl-5-methylcyclohexyl) diphenylphosphine oxideIBA 12/2005
1	Ion Channels (Ion Channel)IBA 07/2005

Therapy/Procedure

2	Therapeutics 11/2009 - 06/2009
1	Intravenous Infusions 11/2016
1	Aftercare (After-Treatment) 02/2009